AzTrials
AzTrials

ElderlyRISING-DOMNCT04132544

Risk Factors for Falls After Intervention of the Urgent Medical Assistance Service (SAMU) in the Elderly Person at Home

A study testing standardized gerontological evaluation (EGS), Proposal for a personalized intervention plan (PIP) and Follow-up in people with Elderly, run by University Hospital, Toulouse at 12 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this project, the investigators are interested in a particular population, that of elderly subjects who used the SAMU after a fall and who are not hospitalized or are hospitalized less than 24 hours. The scientific literature concerning this population is poor . Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Elderly
What is being tested?
standardized gerontological evaluation (EGS), Proposal for a personalized intervention plan (PIP) and Follow-up
Could I receive a placebo?
No, everyone receives an active treatment
How many people
952 participants
Where
12 sitesFrance
Study dates
1 Oct 2019to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Living at home
  • Living at maximum 45 minutes from a hospital center participating in the study (for logistical reasons and practices of study organization)
  • Intervention of the SAMU for a fall at home without there being hospitalization or with hospitalization lasting less than 24h
  • Patient or trusted person capable of giving telephone information
  • Patient or his / her trusted person who has agreed to participate in the study
  • Patient affiliated to a social security scheme

Who cannot join

  • Total dependency (ADL at 0)
  • Entry in nursing home already scheduled within 3 months

Trial locations and contacts

12 sites in 1 country.

12 sites in 1 country

France12 sites
  • CH Albi

    Albi

  • CH Cahors

    Cahors

  • CH Castres-Mazamet

    Castres

  • CHIVA

    Foix

  • CH Lannemezan

    Lannemezan

  • CH Lavaur

    Lavaur

  • CH Montauban

    Montauban

  • CH Rodez

    Rodez

  • CH Ariège Couserans

    Saint-Girons

  • CH Bigorre

    Tarbes

  • University Hospital Toulouse

    Toulouse, 31059

  • Maison de Santé Pluri-professionnelle

    Vic-Fezensac

Other trials in France

About this study

Official title: Impact of an Assessment of Risk Factors for Falls and Personalized Care, on Mortality and Institutionalization, After Intervention of the Urgent Medical Assistance Service (SAMU) in the Elderly Person at Home

In this project, the investigators are interested in a particular population, that of elderly subjects who used the SAMU after a fall and who are not hospitalized or are hospitalized less than 24 hours. The scientific literature concerning this population is poor . However, this is a particularly vulnerable population. The Direction of research, studies, evaluation and statistics (DREES) report notes that in 2005 in metropolitan France, 24% of people aged 65 to 75 said they had fallen in the last 12 months. Home falls among seniors may require emergency medical services (EMS).

Read the detailed description

The first cause of accidental death in people over 65, the fall often has a pejorative impact on the physical, psychological and quality of life . It is also predictive of entry into an institution.

In this project, the investigators propose to evaluate the patient at home with a Gerontological Assessment Nurse working in collaboration with the attending physician, whenever the fall triggers a call to the SAMU (without hospitalization or with hospitalization of less than 24 hours). In addition to the evaluation, the nurse will propose a personalized intervention plan (PIP) based on targeted and prioritized actions.

The Main objective is to study the effect of a personalized intervention plan (PIP) proposed by a Gerontological Assessment Nurse at home in the elderly who used the SAMU for a fall (with on-site care or hospitalization inferior to 24h), on the delay institutionalization or death before institutionalization compared to standard care.

Conditions
Elderly
Being tested
standardized gerontological evaluation (EGS), Proposal for a personalized intervention plan (PIP), Follow-up, Usual care
Keywords
risks factors, Fall Patients, elderly, Urgent Medical Assistance Service, Emergency Care, 911

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standardized gerontological evaluation (EGS)Other

    Evaluation (EGS): initially, the patient benefits from a complete EGS and a complete fall balance realized by a Gerontological Assessment Nurse (initial visit V0) in the 7 working days following the intervention of the SAMU for fall. This assessment is based on the EGS and the assessment of risk factors for falls (HAS, INPES).

  • Proposal for a personalized intervention plan (PIP)Other

    A PIP containing personalized recommendations to improve the patient's state of health, treatment and environment as well as risk factors for falls is proposed during the multi-professional consultation and discussed by telephone with the attending physician (pre-arranged telephone appointment). with the latter).

    The PIP validated by the attending physician is delivered and explained to the patient by the Gerontological Assessment Nurse in the week following the Multidisciplinary Team Meeting (MDTM) during the V1 visit to the patient's home.

  • Follow-upOther

    Four follow-up visits at 6, 12, 18 and 24 months (V2, V3, V4, V5) are performed at the patient's home. During these visits, the Gerontological Assessment Nurse reassesses the person from the gerontological point of view and from the point of view of risk factors for falls.

    A mail containing the elements of interest is sent to the attending physician after each visit. The patient is also contacted by telephone by the Gerontological Assessment Nurse at 2, 4, 9, 15 and 21 months of follow-up to maintain a link, identify possible difficulties and encourage him / her to apply the PIP recommendations.

  • Usual careOther

    The patients included in the "control" group will benefit from the usual care as well as documentation on general recommendations to be put in place to prevent falls and to age in good health [series of brochures published by INPES for the elderly. They are informed by telephone of their home group by the Gerontological Assessment Nurse. The documents are sent by mail to the patient's home address.

Study groups in NCT04132544
Study groupRoleWhat they receive
Intervention groupExperimental* a standardized gerontological evaluation (EGS) and a fall balance performed at home or teleconsultation by a Gerontological Assessment Nurse * the proposal for a Proposal for a personalized intervention plan (PIP) to correct potentially reversible and modifiable factors * a close follow-up by the Gerontological Assessment Nurse for the implementation of the PIP throughout the follow-up period of 24 months (6 home visits and 5 telephone follow-ups).
Receives: Other: standardized gerontological evaluation (EGS); Other: Proposal for a personalized intervention plan (PIP); Other: Follow-up
Comparison group - usual careActive comparatorUsual Care with the provision of documentation on simple recommendations for the prevention of falls and aging well.
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The delay between the T0 and Time of occurrence

    The composite criterion corresponding to the delay between the T0 and the occurrence of an institutionalization or a death before institutionalization (first event occurring).

    In this pilot study, the average age of subjects was 83.6 years. This is a population for which the goals of home care and delay in the onset of dependence and in the occurrence of death are interesting and feasible.

    Measured: 2 years

Secondary outcomes (7)
  1. Number of reminders to the SAMU for fall

    The average number of SAMU recalls for drop during the follow-up period will be compared between the two groups at 12 and 24 months after inclusion. This data is collected from a regional database of regulatory data in partnership with the Regional Health Agency (ARS) for all subjects included.

    Measured: 2 years

  2. Number of non-programmed hospitalizations

    Hospitalizations will be collected for all patients included during the follow-up. We will compare more specifically the unplanned hospitalizations: the average number of unplanned hospitalizations will be compared between the two groups at 12 and 24 months of follow-up.

    This data is collected during the unannounced semi-annual telephone call of the subjects' home groups.

    Measured: 2 years

  3. Evolution of the dependence level evaluated by the ADL scale

    Katz's scale of functional independence for activities of daily living (Katz S, 1963), commonly known as Katz's ADL (Katz Activity of Living Living Scale), is the most appropriate tool for assessing functional abilities. basic patient. Clinicians generally use this tool to detect problems with performing 6 basic activities of daily living and to plan care accordingly. The score varies from 0 (completely dependent) to 6 (completely autonomous). A score of 4 indicates a moderate functional deficit and 2 a severe functional deficit.

    Measured: 2 years

  4. Evolution of the quality-of-life score evaluated by Short Form -12

    The investigators will use the Short Form-12 Quality of Life Scale, which is an abbreviated version of the Medical Outcomes Study Short-Form General Health Survey, with only 12 of the 36 questions that can save a lot of time. It is a generic questionnaire that makes it possible to compare groups of subjects with different pathologies. It measures eight aspects of quality of life that reflect

    World Health Organization (WHO) definition of quality of life: general and mental health, physical and social functioning, physical and emotional health, pain and vitality.

    Compared to the Short Form-36, the Short Form-12 has the advantage of being shorter, less time-consuming, thus easier for the evaluator and better tolerated by patients. Its results are correlated with those of the Short Form-36.

    The Short Form-12 allows to obtain two scores (between 0 and 100, calculated thanks to an algorithm):

    • a score of quality of mental and social life
    • and a physical quality of life score.

    Measured: 2 years

  5. Number of deceased or institutionalized subjects

    The number of deceased or institutionalized subjects during the follow-up period will be compared between the two groups at 12 and at 24 months of follow-up. This data is collected in both groups during the unannounced semiannual telephone call of the groups belonging to the subjects.

    Measured: 2 years

  6. Time to institutionalization

    The time from T0 to the occurrence of institutionalization will be compared between the two groups until the end of the study (i.e. 54 months for the first patient included). This information will be collected in both groups during the semi-annual follow-up telephone calls, blinded to the participants' group allocation.

    Measured: 2 years (up to 54 months for early inclusion)

  7. Time to death

    The time from T0 to the occurrence of death will be compared between the two groups until the end of the study (i.e. 54 months for the first patient included). This information will be collected in both groups during the semi-annual follow-up telephone calls, blinded to the participants' group allocation.

    In the event of institutionalization, the clinical research associate will collect the date and cause of death, if applicable, in both groups within the 12 months following admission to a nursing home and/or before the end of the study.

    Measured: 2 years (up to 54 months for early inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2019
  2. Study start1 Oct 2019
  3. Primary completion30 Apr 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Interventional multicenter and open, randomized study in parallel groups comparing two arms
Masking
None (open label)
Enrolment
952 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04132544
Sponsor's protocol ID
RC31/17/0453
Acronym
RISING-DOM
Status last verified
May 2024
First submitted
15 Oct 2019
Last updated
2 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Bouzid W, Tavassoli N, Berbon C, Qassemi S, Bounes V, Azema O, Shourick J, Nourhashemi F. Impact of a personalised care plan for the elderly calling emergency medical services after a fall at home: The RISING-DOM multi-centre randomised controlled trial protocol. BMC Geriatr. 2022 Mar 4;22(1):182. doi: 10.1186/s12877-022-02850-w.

    PubMed 35246053
  • Bouzid W, Tavassoli N, Berbon C, Qassemi S, Vaysset S, Poly M, Bounes V, Shourick J, Nourhashemi F. Exploring Population Characteristics and Recruitment Challenges in Older People Experiencing Falls at Home without Hospitalization or with an Emergency Department Visit: Insights from the RISING-DOM Experience. Clin Interv Aging. 2023 Dec 1;18:1995-2008. doi: 10.2147/CIA.S421053. eCollection 2023.

    PubMed 38058551
  • Ailliaud A, Moulis E, Vaysset S, Berbon C, Tavassoli N, Bouzid W, Oliveira Soares C, Qassemi S, Nourashemi F. [Assessment in the home of the elderly following a first fall with Samu intervention]. Soins Gerontol. 2022 Jan-Feb;27(153):23-25. doi: 10.1016/j.sger.2021.11.008. Epub 2021 Nov 24. French.

    PubMed 35120719

Questions about this trial

What is this clinical trial studying?

A study testing standardized gerontological evaluation (EGS), Proposal for a personalized intervention plan (PIP) and Follow-up in people with Elderly, run by University Hospital, Toulouse at 12 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 12 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The delay between the T0 and Time of occurrence (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04132544, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in